150 related articles for article (PubMed ID: 8671778)
1. Chronic effects of endothelin-3 on blood pressure and renal haemodynamics in rats.
Martinez F; Deray G; Dubois M; Jacquiaud C; Schmitt F; Jacobs C
Nephrol Dial Transplant; 1996 Feb; 11(2):270-4. PubMed ID: 8671778
[TBL] [Abstract][Full Text] [Related]
2. Vascular actions of endothelin in the rabbit kidney.
Denton KM; Anderson WP
Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):861-72. PubMed ID: 2092953
[TBL] [Abstract][Full Text] [Related]
3. ETA receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney.
Pollock DM; Opgenorth TJ
Br J Pharmacol; 1994 Mar; 111(3):729-32. PubMed ID: 8019752
[TBL] [Abstract][Full Text] [Related]
4. Effect of isradipine on renal haemodynamics and systemic blood pressure changes induced by intravenous infusion of endothelin in healthy humans.
Sørensen SS; Jensen JD; Madsen JK; Pedersen EB
Nephrol Dial Transplant; 1995; 10(8):1324-31. PubMed ID: 8538922
[TBL] [Abstract][Full Text] [Related]
5. Calcitonin gene-related peptide reduces renal vascular resistance and modulates ET-1-induced vasoconstriction.
Amuchastegui CS; Remuzzi G; Perico N
Am J Physiol; 1994 Nov; 267(5 Pt 2):F839-44. PubMed ID: 7977788
[TBL] [Abstract][Full Text] [Related]
6. Diuretic action of the novel loop diuretic torasemide in the presence of angiotensin II or endothelin-1 in anaesthetized dogs.
Uchida T; Hayashi K; Kido H; Watanabe M
J Pharm Pharmacol; 1992 Jan; 44(1):39-43. PubMed ID: 1350626
[TBL] [Abstract][Full Text] [Related]
7. Control of renal function during intrarenal infusion of endothelin.
Stacy DL; Scott JW; Granger JP
Am J Physiol; 1990 May; 258(5 Pt 2):F1232-6. PubMed ID: 2186632
[TBL] [Abstract][Full Text] [Related]
8. Role of endothelin in mediating the attenuated renal hemodynamics in Dahl salt-sensitive hypertension.
Kassab S; Novak J; Miller T; Kirchner K; Granger J
Hypertension; 1997 Sep; 30(3 Pt 2):682-6. PubMed ID: 9323005
[TBL] [Abstract][Full Text] [Related]
9. Effects of endothelin on renal hemodynamics and renal function in anesthetized dogs.
Miura K; Yukimura T; Yamashita Y; Shichino K; Shimmen T; Saito M; Okumura M; Imanishi M; Yamanaka S; Yamamoto K
Am J Hypertens; 1990 Aug; 3(8 Pt 1):632-4. PubMed ID: 2222955
[TBL] [Abstract][Full Text] [Related]
10. Lead and nickel alter the cardiorenal actions of endothelin in the rat.
Novak J; Banks RO
Proc Soc Exp Biol Med; 1995 Feb; 208(2):191-8. PubMed ID: 7831352
[TBL] [Abstract][Full Text] [Related]
11. Contrasting pharmacological ETB receptor blockade with genetic ETB deficiency in renal responses to big ET-1.
Pollock DM
Physiol Genomics; 2001 Jun; 6(1):39-43. PubMed ID: 11395545
[TBL] [Abstract][Full Text] [Related]
12. Renal actions of endothelin-1 in newborn piglets: dose-effect relation and the effects of receptor antagonist (BQ-123) and cyclooxygenase inhibitor (indomethacin).
Bhat R; John E; Chari G; Shankararao R; Fornell L; Gulati A; Vidyasagar D
J Lab Clin Med; 1995 Nov; 126(5):458-69. PubMed ID: 7595031
[TBL] [Abstract][Full Text] [Related]
13. Evidence that insulin-like growth factor I increases renal plasma flow and glomerular filtration rate in fasted rats.
Hirschberg R; Kopple JD
J Clin Invest; 1989 Jan; 83(1):326-30. PubMed ID: 2910916
[TBL] [Abstract][Full Text] [Related]
14. Endothelin ETA receptor-subtype specific antagonism does not mitigate the acute systemic or renal effects of exogenous angiotensin II in humans.
Bayerle-Eder M; Langenberger H; Pleiner J; Polska E; Mensik C; Eichler HG; Wolzt M; Schmetterer L
Eur J Clin Invest; 2002 Apr; 32(4):230-5. PubMed ID: 11952807
[TBL] [Abstract][Full Text] [Related]
15. Systemic and renal effects of an ET(A) receptor subtype-specific antagonist in healthy subjects.
Schmetterer L; Dallinger S; Bobr B; Selenko N; Eichler HG; Wolzt M
Br J Pharmacol; 1998 Jul; 124(5):930-4. PubMed ID: 9692778
[TBL] [Abstract][Full Text] [Related]
16. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure.
Abassi Z; Francis B; Wessale J; Ovcharenko E; Winaver J; Hoffman A
Clin Sci (Lond); 2002 Aug; 103 Suppl 48():245S-248S. PubMed ID: 12193096
[TBL] [Abstract][Full Text] [Related]
17. Cardio-renal effects of endothelin-3 in the rat.
Zimmerman RS; Martinez AJ; MacPhee AA; Barbee RW
Life Sci; 1990; 47(25):2323-32. PubMed ID: 2148203
[TBL] [Abstract][Full Text] [Related]
18. Contribution of prostanoid tp receptors to the pressor and intrarenal haemodynamic response to endothelin.
Williams JM; Pollock DM
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):253-7. PubMed ID: 16487270
[TBL] [Abstract][Full Text] [Related]
19. Effects of renal arterial endothelin-1 and endogenous endothelins on regional kidney blood flow and renal antihypertensive mechanisms in anesthetized rabbits.
Weekes SR; Madden AC; Bergström G; Anderson WP; Evans RG
Kidney Blood Press Res; 2000; 23(6):366-75. PubMed ID: 11070416
[TBL] [Abstract][Full Text] [Related]
20. Antioxidants block angiotensin II-induced increases in blood pressure and endothelin.
Ortiz MC; Manriquez MC; Romero JC; Juncos LA
Hypertension; 2001 Sep; 38(3 Pt 2):655-9. PubMed ID: 11566950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
